Personality Assessment Inventory (PAI) Profiles of Adult Female Abuse Survivors

Assessment ◽  
1994 ◽  
Vol 1 (4) ◽  
pp. 393-399 ◽  
Author(s):  
Joseph Adam Cherepon
Keyword(s):  
Adult Female ◽  
Personality Assessment ◽  
Personality Assessment Inventory ◽  
Analysis Of Covariance ◽  
Abuse Survivors ◽  
Acting Out ◽  
Post Traumatic Stress ◽  
Scale Scores ◽  
History Of ◽  
Primary Affective Disorders

Personality Assessment Inventory (PAI) profiles of 91 adult female, Caucasian subjects were examined to determine if there were significant differences between those subjects who reported a history of broadly-defined childhood/adolescent abuse and those subjects who did not report a history of abuse. PAI profiles of 44 self-reported survivors of abuse were compared with those of 47 subjects diagnosed with primary affective disorders, but without a reported history of abuse. Since there were significant age differences between the two groups, with the nonabused subjects being older, PAI scores were compared using age of subject as covariate in an Analysis of Covariance design. Significant differences between the groups were obtained on several PAI scales and subscales. In addition, the profiles of abuse survivors closely resembled Morey's PAI Cluster 2, which is associated with a diagnosis of post-traumatic stress disorder (PTSD). The PAI scale scores of the abuse survivors were believed to reflect the “acting-out” and “acting-in” tendencies reported in prior PTSD literature. The implications for evaluation of abuse survivors are discussed.

The Generalizability of Overreporting Across Self-Report Measures: An Investigation With the Minnesota Multiphasic Personality Inventory–2–Restructured Form and the Personality Assessment Inventory in a Civil Disability Sample

Assessment ◽  
2015 ◽  
Vol 24 (5) ◽  
pp. 555-574 ◽  
Author(s):  
Adam H. Crighton ◽  
Anthony M. Tarescavage ◽  
Roger O. Gervais ◽  
Yossef S. Ben-Porath
Keyword(s):  
Head Injury ◽  
Personality Assessment ◽  
Minnesota Multiphasic Personality Inventory ◽  
Personality Assessment Inventory ◽  
Personality Inventory ◽  
Self Report ◽  
Validity Scales ◽  
Cognitive Complaints ◽  
Validity Scale ◽  
Scale Scores

Elevated overreporting Validity Scale scores on the Minnesota Multiphasic Personality Inventory–2–Restructured Form (MMPI-2-RF) are associated with higher scores on collateral measures; however, measures used in prior research lacked validity scales. We sought to extend these findings by examining associations between elevated MMPI-2-RF overreporting scale scores and Personality Assessment Inventory (PAI) scale scores among 654 non–head injury civil disability claimants. Individuals were classified as overreporting psychopathology (OR-P), overreporting somatic/cognitive complaints (OR-SC), inconclusive reporting psychopathology (IR-P), inconclusive reporting somatic/cognitive complaints (IR-SC), or valid reporting (VR). Both overreporting groups had significantly and meaningfully higher scores than the VR group on the MMPI-2-RF and PAI scales. Both IR groups had significantly and meaningfully higher scores than the VR group, as well as lower scores than their overreporting counterparts. Our findings demonstrate the utility of inventories with validity scales in assessment batteries that include instruments without measures of protocol validity.

Psychometric properties of the Italian version of the Personality Assessment Inventory (PAI).

2018 ◽  
Vol 30 (9) ◽  
pp. 1226-1236 ◽  
Author(s):  
Claudia Pignolo ◽  
Santo Di Nuovo ◽  
Mario Fulcheri ◽  
Adriana Lis ◽  
Claudia Mazzeschi ◽  
...  
Keyword(s):  
Psychometric Properties ◽  
Personality Assessment ◽  
Personality Assessment Inventory ◽  
Italian Version

scholarly journals An Emulation of Randomized Trials of Administrating Antipsychotics in PTSD Patients for Outcomes of Suicide-Related Events

2021 ◽  
Vol 11 (3) ◽  
pp. 178
Author(s):  
Noah R. Delapaz ◽  
William K. Hor ◽  
Michael Gilbert ◽  
Andrew D. La ◽  
Feiran Liang ◽  
...  
Keyword(s):  
Randomized Clinical Trials ◽  
Previous History ◽  
Current Treatment ◽  
Careful Consideration ◽  
P Value ◽  
Post Traumatic Stress ◽  
Increased Risk ◽  
History Of ◽  
Almost All

Post-traumatic stress disorder (PTSD) is a prevalent mental disorder marked by psychological and behavioral changes. Currently, there is no consensus of preferred antipsychotics to be used for the treatment of PTSD. We aim to discover whether certain antipsychotics have decreased suicide risk in the PTSD population, as these patients may be at higher risk. A total of 38,807 patients were identified with a diagnosis of PTSD through the ICD9 or ICD10 codes from January 2004 to October 2019. An emulation of randomized clinical trials was conducted to compare the outcomes of suicide-related events (SREs) among PTSD patients who ever used one of eight individual antipsychotics after the diagnosis of PTSD. Exclusion criteria included patients with a history of SREs and a previous history of antipsychotic use within one year before enrollment. Eligible individuals were assigned to a treatment group according to the antipsychotic initiated and followed until stopping current treatment, switching to another same class of drugs, death, or loss to follow up. The primary outcome was to identify the frequency of SREs associated with each antipsychotic. SREs were defined as ideation, attempts, and death by suicide. Pooled logistic regression methods with the Firth option were conducted to compare two drugs for their outcomes using SAS version 9.4 (SAS Institute, Cary, NC, USA). The results were adjusted for baseline characteristics and post-baseline, time-varying confounders. A total of 5294 patients were eligible for enrollment with an average follow up of 7.86 months. A total of 157 SREs were recorded throughout this study. Lurasidone showed a statistically significant decrease in SREs when compared head to head to almost all the other antipsychotics: aripiprazole, haloperidol, olanzapine, quetiapine, risperidone, and ziprasidone (p < 0.0001 and false discovery rate-adjusted p value < 0.0004). In addition, olanzapine was associated with higher SREs than quetiapine and risperidone, and ziprasidone was associated with higher SREs than risperidone. The results of this study suggest that certain antipsychotics may put individuals within the PTSD population at an increased risk of SREs, and that careful consideration may need to be taken when prescribed.

Sign in / Sign up

Export Citation Format

Share Document